Skip to content
10-Q

Quarterly Report

CALLISTO PHARMACEUTICALS INC

0001104659-12-078964

← back to feed
Filed
Nov 19, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 19, 2012 158.97M sh
Shares Diluted Q3 2012 · Sep 30, 2012 158.87M sh
Shares Diluted Q3 2012 · Sep 30, 2012 159.2M sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 158.52M sh
Shares Diluted Q3 2012 · Sep 30, 2011 158.23M sh
Capex Q3 2012 · Sep 30, 2012 $117.23K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $120
Cash And Equivalents Q3 2012 · Dec 31, 2011 $13.24M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $67.47K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $1.71M
Stockholders Equity Q3 2012 · Sep 30, 2012 $110.13M
Stockholders Equity Q3 2012 · Dec 31, 2011 $26.18M
Current Liabilities Q3 2012 · Sep 30, 2012 $1.74M
Current Liabilities Q3 2012 · Dec 31, 2011 $4.66M
Total Liabilities Q3 2012 · Sep 30, 2012 $4.4M
Total Liabilities Q3 2012 · Dec 31, 2011 $7.99M
Current Assets Q3 2012 · Sep 30, 2012 $120
Current Assets Q3 2012 · Dec 31, 2011 $14.42M
Total Assets Q3 2012 · Sep 30, 2012 $114.53M
Total Assets Q3 2012 · Dec 31, 2011 $14.51M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.02
Eps Diluted Q3 2012 · Sep 30, 2012 $0.69
Eps Diluted Q3 2012 · Sep 30, 2011 $0.00
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.03
Eps Basic Q3 2012 · Sep 30, 2012 −$0.02
Eps Basic Q3 2012 · Sep 30, 2012 $0.69
Eps Basic Q3 2012 · Sep 30, 2011 $0.00
Eps Basic Q3 2012 · Sep 30, 2011 −$0.03
Sga Expense Q3 2012 · Sep 30, 2012 $418K
Sga Expense Q3 2012 · Sep 30, 2012 $3.18M
Sga Expense Q3 2012 · Sep 30, 2012 $63.55M
Sga Expense Q3 2012 · Sep 30, 2011 $1.29M
Sga Expense Q3 2012 · Sep 30, 2011 $5.12M
Net Income Q3 2012 · Sep 30, 2012 −$3.89M
Net Income Q3 2012 · Sep 30, 2012 $109.88M
Net Income Q3 2012 · Sep 30, 2012 −$13.39M
Net Income Q3 2012 · Sep 30, 2011 −$513.32K
Net Income Q3 2012 · Sep 30, 2011 −$4.78M
Operating Income Q3 2012 · Sep 30, 2012 −$418K
Operating Income Q3 2012 · Sep 30, 2012 −$11.06M
Operating Income Q3 2012 · Sep 30, 2012 −$136.34M
Operating Income Q3 2012 · Sep 30, 2011 −$5.17M
Operating Income Q3 2012 · Sep 30, 2011 −$12.74M